An interventional study of Controlled Diet in Kidney Stone and Urolithiasis, Calcium Oxalate, sponsored by University of Alabama at Birmingham. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Kidney Calculi by University of Alabama at Birmingham — 6 open to participants now, 12 under way, none of them phase 3. Kidney Calculi · University of Alabama at Birmingham.
Among the 17 studies in Kidney Calculi by University of Alabama at Birmingham, this one is the 16th largest by planned enrollment, is the only one that started in 2027, is one of 17 with no phase, reaches primary completion later than 11 of the 11 other live ones, and was the 7th registered.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
Browse Kidney Calculi studies →6 of the 17 studies in Kidney Calculi by University of Alabama at Birmingham are open now, in 1 country. Recruiting first, the newest first:
University of Alabama at Birmingham · Sites in United States
Ages 18–80 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 19–89
University of Alabama at Birmingham · Sites in United States
Ages 18–80
University of Alabama at Birmingham · Sites in United States
Ages 18–80 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18–60 · Healthy volunteers
By country, each count listing its studies:
Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 1 started in 2027.
This study's planned enrollment of 4 is below the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Median enrollment 40 across the 17 interventional studies. Of the 4 that completed or were terminated, 4 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Alabama at Birmingham is the lead sponsor of 1,422 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
4 of the studies in Kidney Calculi by University of Alabama at Birmingham that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04333745University of Alabama at BirminghamInfluence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers | 2026-12-01 |
| NCT04603898University of Alabama at BirminghamOxalate Formation From Ascorbic Acid | 2026-12-01 |
| NCT05417568University of Alabama at BirminghamOxalate-Driven Host Responses in Kidney Stone Disease | 2027-05-30 |
| NCT06210009University of Alabama at BirminghamEffect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease | 2027-08-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 17 studies in Kidney Calculi by University of Alabama at Birmingham, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will consume the controlled diet for five days. Participants will provide urine and blood samples to measure oxalate levels.
Other: Controlled Diet
Participants will consume a controlled low oxalate diet for five days.
Urinary Oxalate Excretion
Urinary oxalate excretion from urine samples will be measured as mg/day
Time frame: Baseline through Day 4
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jul 2027; primary completion for Aug 2031, 49 months later.
Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 49 months is above that.
Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham →